SEC Form 4 · accession 0001103780-15-000040

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CEO · Director · 10% Owner

Period of report

Jan 20, 2010

Accepted (ET)

Aug 7, 2015 · 9:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares	Aug 6, 2015	P	10,000	$0.17	A	4,887,230	D
Common Shares	Aug 6, 2015	P	13,700	$0.18	A	4,900,930	D
Common Shares	Aug 6, 2015	P	5,000	$0.1799	A	4,905,930	D
Common Shares	Aug 6, 2015	P	7,000	$0.1749	A	4,912,930	D
Common Shares	Aug 6, 2015	P	6,000	$0.1749	A	4,918,930	D
Common Shares	Aug 6, 2015	P	5,000	$0.175	A	4,923,930	D
Common Shares	Aug 6, 2015	P	5,000	$0.175	A	4,928,930	D
Common Shares	Aug 7, 2015	P	7,000	$0.1699	A	4,935,930	D
Common Shares	holding	—	—		—	4,488,958	I	Private holding company
Common Shares	holding	—	—		—	4,877,230	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$0.11	holding	—	—	—	Dec 23, 2014	Dec 23, 2019	Common Shares	500,000	500,000	D
Stock Options	$0.35	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	200,000	700,000	D
Stock Options	$0.10	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	225,000	925,000	D
Warrants	$0.25	holding	—	—	—	Mar 21, 2014	Sep 21, 2015	Common Shares	100,067	1,025,067	D
Warrants	$0.25	holding	—	—	—	May 15, 2015	May 15, 2017	Common Shares	170,000	170,000	I